|
Pamicogrel
|
|
101001-34-7
|
|
Propoxybenzene
|
|
622-85-5
|
|
p-Tolyl Salicylate
|
|
607-88-5
|
|
Piperaquine phosphate
|
|
85547-56-4
|
|
Paroxetine mesylate
|
|
217797-14-3
|
|
PX-478 2HCl
|
|
685898-44-6
|
|
PH-064
|
|
892546-37-1
|
|
Prexasertib dihydrochloride
|
|
1234015-54-3
|
|
1,3-Phenylenebis[(4-bromophenyl)methanone]
|
|
136039-69-5
|
|
PBTZ169
|
|
1377239-83-2
|
|
Propargyl-PEG2-acid
|
|
1859379-85-3
|
|
Pyridostatin (RR82) Trifluoroacetate Salt
|
|
1472611-44-1
|
|
PTP1B-IN-2
|
|
1919853-46-5
|
|
PF-06869206
|
|
2227425-05-8
|
|
Procaine penicillin G
|
|
54-35-3
|
|
Pteryxin
|
|
13161-75-6
|
|
PRT 060318
|
|
1194961-19-7
|
|
Psoralenoside
|
|
905954-17-8
|
|
Pembrolizumab (anti-PD-1)
|
|
1374853-91-4
|
|
3,6,9,12-tetraoxapentadec-14-yn-1-ol
|
|
87450-10-0
|
|
PF-05221304
|
|
1370448-25-1
|
|
Potassium guaiacolsulfonate hemihydrate
|
|
78247-49-1
|
|
PF-9366
|
|
72882-78-1
|
|
Protirelin
|
|
24305-27-9
|
|
PMPA tetrasodium salt
|
|
373645-42-2
|
|
Protein kinase inhibitor 1 hydrochloride
|
|
2321337-71-5
|
|
Propafenone
|
|
54063-53-5
|
|
Poziotinib (HM781-36B)
|
|
1092364-38-9
|
|
P7C3-A20
|
|
1235481-90-9
|
|
Paritaprevir (ABT-450)
|
|
1216941-48-8
|
|
PEO-IAA
|
|
6266-66-6
|
|
Phenytoin Sodium
|
|
630-93-3
|
|
2-(p-Tolyl)pyrimidine
|
|
77232-13-4
|
|
Propargyl-PEG6-acid
|
|
1951438-84-8
|
|
2-(p-Tolyl)-1,3-dithiane
|
|
56637-44-6
|
|
Proanthocyanidins
|
|
20347-71-1
|
|
Proctolin TFA
|
|
57966-42-4
|
|
Plantagoside
|
|
78708-33-5
|
|
Pralatrexate (NSC 754230)
|
|
146464-95-1
|
|
PD 117519 (CI947)
|
|
96392-15-3
|
|
Peficitinib (ASP015K)
|
|
944118-01-8
|
|
PEG5-Carboxylic Acid tert-Butyl Ester
|
|
518044-32-1
|
|
3PO
|
|
18550-98-6
|
|
Polaprezinc
|
|
107667-60-7
|
|
1-Phenyl-1H-imidazol-3-ium Trifluoromethanesulfonate
|
|
361447-81-6
|
|
PLP（139-151）TFA
|
|
122018-58-0
|
|
2-Phenylethyl n-Octanoate
|
|
5457-70-5
|
|
PF-07321332
|
|
2628280-40-8
|
|
Pardoprunox (SLV-308) hydrochloride
|
|
269718-83-4
|
|
Pertuzumab (anti-HER2)
|
|
380610-27-5
|
|
PAMP-20 (human) TFA
|
|
150238-87-2
|
|
PF-573228
|
|
869288-64-2
|
|
PF-04995274
|
|
1331782-27-4
|
|
2-(2-Pyridinyldithio)ethanol
|
|
111625-28-6
|
|
Practolol
|
|
6673-35-4
|
|
Parathyroid hormone (1-34) (rat) TFA
|
|
98614-76-7
|
|
Propargyl-PEG4-NHS ester
|
|
1428629-70-2
|
|
PIK-III
|
|
1383716-40-2
|
|
PTP1B-IN-9
|
|
145888-79-5
|
|
PDEC-NB
|
|
874302-76-8
|
|
Porcn-IN-1
|
|
2036044-77-4
|
|
PG 931 TFA
|
|
667430-81-1
|
|
Pectolinarigenin
|
|
520-12-7
|
|
Picfeltarraenin IB
|
|
97230-46-1
|
|
Paederosidic acid methyl ester
|
|
122413-01-8
|
|
Propargyl-PEG7-acid
|
|
2093154-00-6
|
|
PF-6260933
|
|
1811510-56-1
|
|
Phe-Lys(Trt)-PAB
|
|
1116085-99-4
|
|
PHM 27 (human) TFA
|
|
87403-73-4
|
|
Pralidoxime Iodide
|
|
94-63-3
|
|
Pantoprazole Sodium Sesquihydrate
|
|
164579-32-2
|
|
PHA-665752
|
|
477575-56-7
|
|
Pelabresib (CPI-0610)
|
|
1380087-89-7
|
|
PH-002
|
|
1311174-68-1
|
|
PZ-2891
|
|
2170608-82-7
|
|
p-Xylenolphthalein
|
|
50984-88-8
|
|
PD173955
|
|
260415-63-2
|
|
Pacritinib (SB1518)
|
|
937272-79-2
|
|
PF-562271 HCl
|
|
939791-41-0
|
|
Prilocaine
|
|
721-50-6
|
|
PF9601N
|
|
133845-63-3
|
|
PF-3450074
|
|
1352879-65-2
|
|
Propargyl-PEG4-acid
|
|
1415800-32-6
|
|
Polydatin
|
|
65914-17-2
|
|
PKG drug G1
|
|
374703-78-3
|
|
2PACz
|
|
20999-38-6
|
|
PS210
|
|
1221962-86-2
|
|
Polyimide powder
|
|
62929-02-6
|
|
Pyridoxine HCl
|
|
58-56-0
|
|
PDM-11
|
|
1032508-03-4
|
|
PF-06282999
|
|
1435467-37-0
|
|
Phaseoloidin
|
|
118555-82-1
|
|
Promethazine
|
|
60-87-7
|
|
Pocapavir
|
|
146949-21-5
|
|
4-(3-Pyridyl)phenylboronic Acid Hydrochloride (contains varying amounts of Anhydride)
|
|
2377369-59-8
|
|
Proguanil
|
|
500-92-5
|
|
Piperoxan hydrochloride
|
|
135-87-5
|
|
PKC-theta inhibitor
|
|
736048-65-0
|
|
P7C3-Ome
|
|
313268-18-7
|
|
2-(1-Pyrrolidinyl)ethanamine Dihydrochloride
|
|
65592-36-1
|